Document Detail


Adrenocortical Cancer Update.
MedLine Citation:
PMID:  24857583     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Although preoperative clinical, biochemical, and radiologic features can aid in the diagnosis of adrenocortical cancer (ACC), uncertainty often remains. This diagnostic ambiguity and the subsequent potential for an inadequate surgical resection have likely contributed to the currently dismal disease-free survival, although unsettlingly high rates of locoregional recurrences still persist even in the setting of a supposedly R0 resection. Refinements in both diagnostic criteria and surgical techniques, as well as the increasing use and study of novel multimodality therapies for ACC, have provided advances in the treatment of these patients, and renewed hope for meaningful improvements in patient outcomes.
Authors:
Ryaz Chagpar; Allan E Siperstein; Eren Berber
Related Documents :
23471843 - Decision making in the management of recurrent head and neck cancer.
24793103 - A review of the surgical management of sacral chordoma.
24488383 - How important is the number of pelvic lymph node retrieved to locorregional staging of ...
Publication Detail:
Type:  REVIEW     Date:  2014-4-4
Journal Detail:
Title:  The Surgical clinics of North America     Volume:  94     ISSN:  1558-3171     ISO Abbreviation:  Surg. Clin. North Am.     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-5-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0074243     Medline TA:  Surg Clin North Am     Country:  -    
Other Details:
Languages:  ENG     Pagination:  669-687     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Subclinical Cushing Syndrome: A Review.
Next Document:  Nonfunctional Pancreatic Neuroendocrine Tumors.